The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday:** Shire Plc and U.S. drugmaker Abbvie Inc plan to announce a $53 billion merger as soon as Friday morning, two people said.** Allergan Inc, trying to fend off a hostile takeover bid from Valeant Pharmaceuticals International Inc , has thrown up obstacles to a special shareholders meeting, its biggest investor said.
AbbVie Inc. (AbbVie) is a research-based pharmaceuticals company. Shares of ABBV fell by 0.24% or $-0.13/share to $53.52. In the past year, the shares have traded as low as $42.25 and as high as $58.27. On average, 6589790 shares of ABBV exchange hands on a given day and today's volume is recorded at 18659408.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 0.04% or $0.07/share to $165.82. In the past year, the shares have traded as low as $86.95 and as high as $174.49. On average, 4143340 shares of AGN exchange hands on a given day and today's volume is recorded at 1376073.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 0.16% or $-0.19/share to $121.52. In the past year, the shares have traded as low as $89.76 and as high as $153.10. On average, 3480610 shares of VRX exchange hands on a given day and today's volume is recorded at 2542916.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 0.03% or $-0.04/share to $130.74. In the past year, the shares have traded as low as $92.42 and as high as $170.45. On average, 357319 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 176279.
Source
